Due to the highly regulated nature of our industry and in order to preserve patient safety, we cannot provide our products in development to patients. However, we endeavor, together with our pharmaceutical partners, to move our potential therapeutics forward into clinical studies so that they may become available for affected patients as soon as possible.
We regret that we are not able to provide more detail on the possible timelines and availability of SNIM® RNA therapeutics at this point.
We encourage you to stay informed about new developments in the field of SNIM® RNA therapeutics, and to stay in touch with us at www.ethris.com. We would also advise you to regularly speak to your doctor about new treatments that may become available.